Premier Alternatives

NFlection Therapeutics

Boston, MA · Founded 2014 · Privately Held (backing)

Developer of topical therapies designed to address rare skin disorders associated with abnormal RAS pathway activity. NFlection Therapeutics is based in Boston, MA and was founded in 2014. It was valued at $156 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $65.5 million across 3 recorded rounds; the latest was a $4 million seed round in Jul 2023.

PMV mark · valuation
$156.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$65.5M
Last round
Seed Round
Jul 2023

NFlection Therapeutics key facts

as of Oct 2026
  • Developer of topical therapies designed to address rare skin disorders associated with abnormal RAS pathway activity.
  • NFlection Therapeutics is valued at approximately $156.0M as of Oct 2026, set at its later-stage round, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $65.5M across 3 recorded rounds; the latest was Seed Round ($4.0M) in Jul 2023.
  • Notable investors include F-Prime Capital, Eight Roads, venBio, Children's Tumor Foundation, U.S. Department of Health and Human Services.
  • NFlection Therapeutics has filed 4 Form Ds with the SEC since 2017, most recently Jul 2023 ($4.0M sold to 2 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$156.0M

Valued at $156.0M at its later-stage round, Aug 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of NFlection Therapeutics with a free account
  • ·Watch NFlection Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

NFlection Therapeutics funding rounds

3 rounds
Jul 2023Seed Round$4.0MSEC filing▮
Jun 2022Early Stage VC$20.0MSEC filing▮
Dec 2016Seed Round$1.4MSEC filing▮
Full funding history →

NFlection Therapeutics valuation

NFlection Therapeutics was valued at $156 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has NFlection Therapeutics raised?

NFlection Therapeutics has raised $65.5 million in total; 3 of its rounds are on record, from 2016 on. The largest on record was a $4 million seed round in Jul 2023.

NFlection Therapeutics has filed 4 Form Ds with the SEC since 2017, most recently in Jul 2023 ($4 million sold to 2 investors).

NFlection Therapeutics investors

5 investors are on record for NFlection Therapeutics, including F-Prime Capital, Eight Roads, venBio and Children's Tumor Foundation. The seed round in Jul 2023 drew 2 investors.

About NFlection Therapeutics

Developer of topical therapies designed to address rare skin disorders associated with abnormal RAS pathway activity. The company offers MEK inhibitors applied to the skin, enabling patients with uncommon dermatological conditions to receive localized treatment focused on disease control.

Sector
Healthcare
HQ
Boston, MA, United States
Founded
2014
Employees
6
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.